First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial.

Dani, Sameer; Costa, Ricardo A; Joshi, Hasit; Shah, Jay; Pandya, Rashmit; Virmani, Renu; Sheiban, Imad; Bhatt, Sanjeev; Abizaid, Alexandre

Dani, Sameer; Costa, Ricardo A; Joshi, Hasit; Shah, Jay; Pandya, Rashmit; Virmani, Renu; Sheiban, Imad; Bhatt, Sanjeev; Abizaid, Alexandre.

Affiliation

Dani S; Lifecare Institute of Medical Sciences and Research, Ahmedabad, Gujarat, India. drsameerdani@gmail.com

EuroIntervention ; 9(4): 493-500, 2013 Aug 22.

Article in En | MEDLINE | ID: mdl-23965355

Subject(s)

Coronary Artery Disease/therapy; Coronary Vessels/surgery; Drug-Eluting Stents; Sirolimus/therapeutic use; Adult; Aged; Coronary Restenosis/therapy; Drug-Eluting Stents/adverse effects; Female; Humans; Male; Middle Aged; Polymers; Prospective Studies; Sirolimus/adverse effects; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Coronary Vessels / Sirolimus / Drug-Eluting Stents Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: EuroIntervention Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPEUTICA Year: 2013 Document type: Article Affiliation country: India Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google